secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tevogen Bio Holdings Inc. (TVGN)
CIK:        0001860871
Form:       8-K
Filed at:   2025-07-03T23:59:59+00:00
Accession:  0001641172-25-017873
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tevogen Bio enters $50M at-the-market equity sales agreement with A.G.P.
------------------------------------------------------------------------

- Sales agreement allows issuance and sale of up to $50M of common stock from time to time.
- Sales will be made through A.G.P./Alliance Global Partners as agent at market prices.
- Offering conducted under effective shelf registration statement (File No. 333-288218).
- Company pays agent a commission on gross proceeds and provides customary indemnification.
- Company is not obligated to sell any shares and may terminate the agreement at any time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860871/000164117225017873/0001641172-25-017873-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860871/000164117225017873/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-017873

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer